Drug intelligence / Profile preview

morphine + oxidized cellulose

Development stage: Unknown
Modality: Small Molecules
Administration: Topical

Overview

Morphine + oxidized cellulose is a combination product consisting of morphine, a potent opioid analgesic, and oxidized cellulose, a bioabsorbable hemostatic agent. Morphine acts primarily as an agonist at the mu-opioid receptor in the central nervous system to provide analgesia for moderate to severe pain. Oxidized cellulose is used topically to control bleeding during surgical procedures by promoting clot formation and providing a physical matrix for platelet aggregation. The combination may be used in surgical settings where both pain management and local hemostasis are required.

Targets

KOR (Kappa opioid receptor)MOR (Mu opioid receptor)DOR (Opioid Receptor Delta 1)

Beyond the preview

Go deeper on morphine + oxidized cellulose.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on morphine + oxidized cellulose.

Explore the full profile